STEPHANIE WORTH: Open Payments
NPI 1801203112 · HARVEY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,285 in 47 payments from 15 companies in 2025. Trend: 2023 $1,483 · 2024 $1,201 · 2025 $1,285
Food & beverage: $1,285
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $349 |
| Amgen Inc. | 5 | $192 |
| Alnylam Pharmaceuticals Inc. | 5 | $148 |
| Merck Sharp & Dohme LLC | 6 | $112 |
| E.R. Squibb & Sons, L.L.C. | 5 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75 |
| ABIOMED | 3 | $62 |
| Esperion Therapeutics, Inc. | 3 | $58 |
| PFIZER INC. | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
Products named: Wegovy, REPATHA, ONPATTRO, Ozempic, VERQUVO, JARDIANCE, CAMZYOS, NEXLETOL.
Industry payments across LA — which companies pay providers there.
